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hypothesize that patients with Chronic Kidney Disease compared
with non-Chronic Kidney Disease have reduced platelet aggrega-
tion and poor platelet inhibitory response to DAP (aspirin and
clopidogrel).
Methods: In this study we have studied 210 patients with CAD
who underwent PTCA and started on aspirin and clopidogrel 75
mg twice a day. Platelet aggregation test was performed in all
patients after 15 days. Estimated GFR is calculated in all the pa-
tients according to MDRD formula. Patients were classified into 4
categories. Group 1with GFR >90, group 2 with GFR 60-90, group 3
with GFR 30-60, group 4 with GFR <30. The effect GFR on platelet
inhibition is studied in all groups.
Results: 210 patients who underwent PTCA who are included in
this study 166 were male patients and 44 were female patients.
Among them 72 were non hypertensives and 138 were hyperten-
sives. Diabetes is seen in 89 patients and 129 patients were non
diabetics. Out of the 210 patients 75 were present and ex-smokers
135 were non smokers. Among the study population 20 were al-
coholics and 190 were non alcoholics. Only 5 patients in the study
population had a significant family history of CAD. 93 patients
who underwent PTCA presented with acute coronary syndrome
(ACS) whereas 117 patients presented with chronic stable angina
(CSA). 142 patients who underwent PTCA had good LV function, 32
had mild LV dysfunction, 12 had moderate LV dysfunction and 24
severe LV dysfunction. 20 patients had a history of CABG done in
the past. 102 patients underwent the procedure through femoral
route and 108 patients through the radial route. 7 CTO lesions
were found and 150 type B2 lesions, 8 type B1 lesions, 27 type C
lesions were found.
The mean age in the study population is 55.12+10.5 yr. The
mean haemoglobin level in the study population of is 12.9+2.09 gm
%. The mean TLC count was 9039+2840/ mm3. The mean platelet
count was 2.4228+0.8065 lakhs. The mean total cholesterol level is
138.08+40.33gm/dl. The mean LDL level was 71.08+33.94gm/dl.
The mean HDL level was 41.15+12.94gm/dl. The mean VLDL level
was 26.40+14.53gm/dl. The mean TG level was 124.76+72.05gm/dl.
The mean height was 157.85+ 8.32 cm. The mean weight was
63.935 +9.697 kg. Themean stent size was 2.8220 +0.3077 mm. The
mean LP (a) level was 54.84 +59.38. The two sample t test does not
show any significant difference between the group with normal
GFR and those with decreased GFR. The regression analysis
revealed significant difference in p value in smokers and longer
stent length.
Conclusions: CKD patients showed effective platelet inhibition
post PTCA with clopidogrel after 14 days and there is no need of
change in the antiplatelet regimen for these subset of patients.
There is no statistically significant difference in patients with CKD
and normal GFR. Only stent length and smoking significantly in-
fluence platelet inhibition in this subset.
A study of correlation of red cell distribution width
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Background: Red cell distribution width (RDW) is a measure of the
variability in the size of circulating erythrocytes, commonly uti-
lized in the differential diagnosis of anemia. It has been shown
that RDW is closely related to the prognosis and long term adverse
events of cardiovascular diseases. The aim of the present study
was to prospectively evaluate the severity of coronary artery dis-
ease by angiography and RDW at Osmania General Hospital,
Hyderabad.
Methods: A total of 132 consecutive patients who were admitted
into cardiology department due to the presence of typical angina
and/or positive treadmill test and underwent coronary angiog-
raphy were enrolled in the study .Based on the results of the
coronary angiography the patients were divided into two groups,
CAD group (n¼105) and control group (n¼27).The severity of CAD
in each patient after angiography was evaluated by Modified
Gensini score, and its relationship with RDW was analyzed.
Results: On analysis, the mean age of patients with CAD was
51.74±11.20yrs and in controls was 48.22 ± 9.51 yrs. Male :Female
ratio was 3.03:1 (n¼79,n¼26).In patients with CAD smokers
constituted about 53.3%(n¼56),diabetics were about
32.3%(n¼34),those with hypertension were 68.57%(n¼72).family h/
o CAD was seen in 21%(n¼23).In patients with CAD, mean Hb was
13.4±1.4,mean RDWwas 16.62±1.47where as in controls themean
Hb was 13.1±1.2,mean RDWwas 14.37±1.55.There was significant
correlation of RDW in patients with high Gensini score( >13) by
ANOVA analysis (p¼0.05). RDW correlated with severity of CAD
when the Gensini score was >6.
Conclusion: RDW is associated with both presence of CAD and
severity of coronary stenosis. It can be a readily available,
economical marker for the prediction of CAD. A High RDW pre-
dicts a significantly severe CAD on angiography.
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Background: Postinfarction angina is not an uncommon compli-
cation after myocardial infarction (MI). Because of its high risk
score (Unstable angina class III; Risk score 9 if rest angina<48
hours post MI), guidelines recommend early intervention in these
patients. However, financial constraints and lack of wide insur-
ance coverage in developing countries prohibit intervention in
deserving patients. We sought to analyze whether addition of
eptifibatide (which acts by inhibiting platelet aggregation, a key
mechanism in postinfarction angina) would add to the benefit
achieved by intensified antianginal therapy alone in patients with
postinfarction angina unwilling for intervention.
Methods: 461 patients of postinfarction angina who refused to
undergo early intervention were assigned in a 1:1 manner to
receive either eptifibatide (180 mg/kg bolus followed by 2.0 mg/kg/
min infusion for 24 hours) along with intensification of anti-
anginal therapy (Group A; n¼229) or intensified antianginal ther-
apy alone (Group B; n¼232). The primary end points were
composite of all cause death and non fatal myocardial infarction
at 30 days.
Results: Primary composite end points did not differ between the
two groups (16.2% versus 18.9% in group A and group B, odds ratio
[OR], 0.82; 95% confidence interval [CI], 0.5-1.30; p value¼
0.43).Recurrent angina was lower in the group A (8.3% versus
17.7%; OR, 0.42; 95% CI, 0.27-0.75; p value¼ 0.003). Total time to
reach pain free status (as measured by patient on visual analogue
scale) was lower in the group A when compared to the group B
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(p value¼0.05). On bleeding academic research consortium (BARC)
scale, type 1 and 2 bleeding were higher with eptifibatide (OR, 3.18;
95% CI, 1.76-5.74; p value¼ 0.0001), however the more serious
(composite of type 3 and 5) bleeds did not differ between the two
groups (OR, 1.73; 95% CI, 0.7-4.08; p value¼ 0.21).
Conclusion: Patients with postinfarction angina, unwilling for
intervention, had reduced incidence of recurrent angina and
earlier relief of anginal symptoms, when eptifibatide was added to
intensified antianginal therapy. This, it achieved without causing
significant difference in the primary composite end points.
Although significant increase was noted in types 1 and 2 BARC
bleeding in the group A, incidence of higher degree bleeds did not
differ significantly between the two groups.
Impact of pre infarction angina (PIA) in STEMI
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Background: Mortality of STEMI even in the current coronary
intervention era is 7-8%. The relationship between pre infarction
angina (PIA) and mortality has been studied in the past. However
factors that determine favorable outcome in preinfarction angina
have not been studied in our population. In this context, this study
has been done to evaluate the relationship between preinfarction
angina and its beneficial effect in STEMI outcome.
Aim: To evaluate outcome of pre infarction angina in STEMI pa-
tients, related to CK-MB level, baseline
LV function on admission and in-hospital outcome and
mortality.
Methods: Non Randomized Observational (Prospective Study)
Study Period e July (1-31) 2014.
STEMI Patients Admitted In CCU
Inclusion criteria: 1. All AWMI as a first ACS event (acute or
recent not old) irrespective of comorbid conditions and risk fac-
tors 2. All AWMI lysed (or) treated by conservative management
Results: Total no of patients observed n¼29. Out of these PIA
present in 10 patients. PIA absent in 19 patients. CK-MB median
level after admission was lower in PIA positive group. Baseline LV
function was also better in PIA postive group (median EF ¼ 45%).
Complications like Arrythmia, Cardiogenic shock and freewall
rupture were absent in pia positive group. Mortality was also nil
PIA positive group.
Conclusion: Presence of preinfarction angina in anterior STEMI is
associated with lower in-hospital mortality, better LV-function
and preserves electrical stability in our population.
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Objective: This study was undertaken to correlate the magnitude
of T inversion following thrombolysis in acute STEMI with Infarct
Related Artery (IRA) patency.
Background: Although many studies have demonstrated the as-
sociation between early T wave inversion after thrombolysis and
angiographic patency, T wave inversion magnitude after suc-
cessful lysis with resolved ST segment was further evaluated in
relation to IRA patency.
Methods: This is a prospective observational study done during
the month of April 2014 in tertiary care hospital. A total of twenty
patients, age ranging from 32 to 60 yrs with anterior and inferior
wall STEMI who were treated with I.V streptokinase as per pro-
tocol on admission and predischarge coronary angiogram was
done within 5 days of admission . Patient stratification was done
based on the depth and width of maximally inverted negative T
waves, ejection fraction and it was correlated with angiographic
patency of IRA.
Results: Among the twenty patients, recanalised IRA was found in
2 patients who had more broad and deeply inverted T waves in
ECG. In the remaining 18 patients, deeper inverted T waves in 12
patients was associated with better patency rate of IRA(70% vs
30%), lower peak CPK value (250+/_50 vs 400+/-100) better EF (50+/
_10% vs 35+/_5%) than the 6 patients who had small inverted T
waves .
Conclusion: Early T wave inversion as quoted earlier has good
correlation with IRA patency. Also some correlation was found
between quantum of T wave inversion with IRA patency. How-
ever, this was not linear and further studies are required.
Tailored thrombolytic therapy for ST-elevation MI
(STEMI) in very elderly patients
Y. Vijayachandra Reddy, S.I. Singha
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Background: The optimal reperfusion strategy in very elderly pa-
tients (age >80years) with STEMI still remains a topic of debate.
This may largely be attributed to omission / under-representation
of the very elderly in clinical trials. Tailored thrombolytic therapy
(TLT) may be an appropriate option for such selected individuals,
even in this era of primary PCI. Here, we present our single-unit
experience in tailored thrombolysis for very elderly over the last 5
years.
Materials and Methods: We did 8 cases of reperfusion therapy in
the very elderly over the last 5 years. There were 5 males and 3
females and were in the age group of 80 e 90 years. 5 patients
presented with acute IWMI and 3 patients with acute AWMI. 3
patients had creatinine levels > 2 mg/dl. 3 patients were under-
weight (<50 kg), 2 patients had COPD and 2 patients had gastritis.
The options of primary PCI and thrombolytic therapy were dis-
cussed; after which, 3 patients opted for primary PCI and stenting.
The remaining 5 patients were discussed regarding conventional
thrombolysis & tailored thrombolysis (TLT), and the higher risk of
bleeding with conventional thrombolysis. They were then taken
up for tailored thrombolytic therapy. The regimen included an
initial IV Tenecteplase 0.25 mg/Kg (half-dose Tenecteplase) fol-
lowed by assessment for resolution of symptoms (chest pain) and
ECG changes of ST segment resolution at 30 minutes after TLT. If
the first thrombolysis was unsuccessful, the remaining half dose
of IV tenecteplase had to be given.
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